Condensed Statements of Cash Flows (Unaudited) - USD ($)	7 Months Ended	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2020
OPERATING ACTIVITIES
Net income (loss)	$ 230,806	$ (599,011)
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:
Interest earned on cash and marketable securities held in Trust Account	(1,151,957)	(1,016,923)
Change in operating assets and liabilities:
Prepaid expenses	(187,100)	(16,438)
Receivable from related parties	(30,054)	(8,126)
Other non-current assets	(53,368)	33,327
Accounts payable	96,632	(118,016)
Payable to related parties		(10,464)
Accrued liabilities	5,000	150
Other current liabilities	293,362	(180,696)
Net cash and cash equivalents used in operating activities	(796,679)	(1,916,197)
INVESTING ACTIVITIES
Investment of cash in Trust Account	(172,500,000)
Cash withdrawn from Trust Account	71,590	727,119
Net cash and cash equivalents provided by (used in) investing activities	(172,428,410)	727,119
FINANCING ACTIVITIES
Proceeds from sale of common stock to Founders	25,000
Borrowing from related party	99,937
Repayment of borrowing from related party	(99,937)
Proceeds from sale of Private Placement Units	5,675,000
Proceeds from sale of common stock to underwriters	1,200,000
Proceeds from sale of Units, net of underwriting discounts paid	169,050,000
Payment of offering costs	(689,210)
Net cash and cash equivalents provided by financing activities	175,260,790
Net change in cash and cash equivalents during period	2,035,701	(1,189,078)
Cash and cash equivalents, beginning of period		1,576,508
Cash and cash equivalents, end of period	2,035,701	387,430
SUPPLEMENTAL DISCLOSURES
Cash paid for income taxes	50,382	462,238
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Offering costs included in accounts payable	193,220
Change in value of common stock subject to possible redemption	$ 2,130,800	$ (599,020)